CA
CHI Advisors Portfolio holdings
AUM
$252M
1-Year Est. Return
56.99%
This Fund
S&P 500
1 Year Est. Return
+56.99%
AUM
$329M
AUM Growth
-$47.2M
(-13%)
Holding
30
Top Buys
| 1 | +$54.5M | |
| 2 | +$6.18M | |
| 3 | +$4.85M | |
| 4 |
Disc Medicine
IRON
|
+$4.44M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$3.94M |
Top Sells
| 1 | +$100M | |
| 2 | +$32.5M | |
| 3 | +$4.44M | |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$3.13M |
| 5 |
Kezar Life Sciences
KZR
|
+$2.16M |
Sector Composition
| 1 | Healthcare | 98.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Entrada Therapeutics
TRDA
$455M
| – | – |
-56,374
|
|
||
|
KDNY
27
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-135,000
|
|
||
|
ONCR
28
DELISTED
Oncorus, Inc.
ONCR
| – | – |
-2,367,436
|
|
||
|
RXDX
29
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-934,135
|
|
||
|
30
Kezar Life Sciences
KZR
$49.9M
| – | – |
-68,945
|
|